251 related articles for article (PubMed ID: 25078717)
1. The influence of ictal cutaneous allodynia on the response to occipital transcutaneous electrical stimulation in chronic migraine and chronic tension-type headache: a randomized, sham-controlled study.
Bono F; Salvino D; Mazza MR; Curcio M; Trimboli M; Vescio B; Quattrone A
Cephalalgia; 2015 Apr; 35(5):389-98. PubMed ID: 25078717
[TBL] [Abstract][Full Text] [Related]
2. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
[TBL] [Abstract][Full Text] [Related]
4. Migraine Prevention Using Different Frequencies of Transcutaneous Occipital Nerve Stimulation: A Randomized Controlled Trial.
Liu Y; Dong Z; Wang R; Ao R; Han X; Tang W; Yu S
J Pain; 2017 Aug; 18(8):1006-1015. PubMed ID: 28428093
[TBL] [Abstract][Full Text] [Related]
5. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
Haas DC; Sheehe PR
Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
[TBL] [Abstract][Full Text] [Related]
6. A good preoperative response to transcutaneous electrical nerve stimulation predicts a better therapeutic effect of implanted occipital nerve stimulation in pharmacologically intractable headaches.
Nguyen JP; Nizard J; Kuhn E; Carduner F; Penverne F; Verleysen-Robin MC; Terreaux L; de Gaalon S; Raoul S; Lefaucheur JP
Neurophysiol Clin; 2016 Feb; 46(1):69-75. PubMed ID: 26895733
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache.
Kalita J; Laskar S; Bhoi SK; Misra UK
J Neurol; 2016 Nov; 263(11):2238-2246. PubMed ID: 27541044
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Allodynia and Its Risk Factors in Korean Patients with Migraine: A Survey of Two Tertiary Care Hospitals.
Kim SY; Park SP
J Oral Facial Pain Headache; 2016 Fall; 30(4):323-329. PubMed ID: 27792800
[TBL] [Abstract][Full Text] [Related]
9. Generalized neck-shoulder hyperalgesia in chronic tension-type headache and unilateral migraine assessed by pressure pain sensitivity topographical maps of the trapezius muscle.
Fernández-de-las-Peñas C; Madeleine P; Caminero AB; Cuadrado ML; Arendt-Nielsen L; Pareja JA
Cephalalgia; 2010 Jan; 30(1):77-86. PubMed ID: 19515127
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study.
Lu SR; Fuh JL; Wang SJ; Juang KD; Chen SP; Liao YC; Wang YF
Pediatrics; 2013 Jul; 132(1):e9-e16. PubMed ID: 23776112
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache.
Atasoy HT; Atasoy N; Unal AE; Emre U; Sumer M
Eur J Pain; 2005 Jun; 9(3):285-91. PubMed ID: 15862478
[TBL] [Abstract][Full Text] [Related]
12. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
Silberstein SD; Young WB; Hopkins MM; Gebeline-Myers C; Bradley KC
Headache; 2007 Jun; 47(6):878-85. PubMed ID: 17578539
[TBL] [Abstract][Full Text] [Related]
13. Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study.
Cho SJ; Sohn JH; Bae JS; Chu MK
Headache; 2017 Nov; 57(10):1583-1592. PubMed ID: 28940352
[TBL] [Abstract][Full Text] [Related]
14. Functional alterations of pain processing pathway in migraine patients with cutaneous allodynia.
Chen N; Zhang J; Wang P; Guo J; Zhou M; He L
Pain Med; 2015 Jun; 16(6):1211-20. PubMed ID: 25645315
[TBL] [Abstract][Full Text] [Related]
15. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous Supraorbital Stimulation as a Preventive Treatment for Chronic Migraine: A Prospective, Open-Label Study.
Ordás CM; Cuadrado ML; Pareja JA; de-Las-Casas-Cámara G; Gómez-Vicente L; Torres-Gaona G; Venegas-Pérez B; Álvarez-Mariño B; Diez Barrio A; Pardo-Moreno J
Pain Med; 2020 Feb; 21(2):415-422. PubMed ID: 31131857
[TBL] [Abstract][Full Text] [Related]
17. The analysis of allodynia in patients with idiopathic intracranial hypertension.
Ekizoglu E; Baykan B; Orhan EK; Ertas M
Cephalalgia; 2012 Oct; 32(14):1049-58. PubMed ID: 22875880
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
Limmroth V; Biondi D; Pfeil J; Schwalen S
Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
20. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
Silberstein SD; Calhoun AH; Lipton RB; Grosberg BM; Cady RK; Dorlas S; Simmons KA; Mullin C; Liebler EJ; Goadsby PJ; Saper JR;
Neurology; 2016 Aug; 87(5):529-38. PubMed ID: 27412146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
